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FoxO3a Is an Antimelanogenic Factor that Mediates
Antioxidant-Induced Depigmentation
Juewon Kim1,2, Hyunjung Choi1, Eun-Gyung Cho1 and Tae R. Lee1
Forkhead box-O (FoxO) family transcriptional factors control the expression of many genes involved in a variety
of cellular processes. Melanogenesis is an oxidizing process; therefore, many antioxidants are used to inhibit
melanin production. However, their mechanism of action is poorly understood. In this study, we investigated the
role of FoxO3a, which is a key factor in oxidative stress–related cellular responses in melanogenesis. When
FoxO3a expression was inhibited, the expression of melanogenic genes and melanin levels increased. In contrast,
the overexpression of wild-type FoxO3a and the increased nuclear translocation induced by the phosphoinosi-
tide 3-kinase inhibitors or by Akt inhibition reversed these phenomena. This effect was not observed when
FoxO3a harbored a deletion in the nuclear localization signal, indicating that its nuclear translocation is important
for the regulation of melanogenesis. When antioxidants such as vitamin C, N-acetylcysteine, and Trolox were
applied to MNT1 cells, melanin levels decreased in parallel with FoxO3a nuclear translocation, and this effect
disappeared with FoxO3a-directed small interfering RNA treatment. Because FoxO3a orchestrates the expression
of many genes in order to regulate cellular phenotypes in a variety of environmental states, this gene, a factor
involved in melanogenesis regulation, may represent a good target for studying antimelanogenic signaling
pathways and for designing pharmacological or antimelanogenic agents that regulate melanin synthesis.
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INTRODUCTION
Class O forkhead/winged helix transcription factors (FoxO),
which are widely conserved from Caenorhabditis elegans to
mammals, display a wide range of organismal functions that
orchestrate gene expression programs activated by a variety of
cellular processes, such as the cell cycle, apoptosis, DNA
repair, energy metabolism, development, and protection from
oxidative stress (Nakae et al., 2002; Blucher et al., 2003;
Holzenberger et al., 2003; Hu et al., 2004; Paik et al., 2007).
Four members of the mammalian FoxO family have been
identified: FoxO1, FoxO3a, FoxO4, and FoxO6. These FoxO
transcription factors are involved in cellular signaling and are
triggered by a variety of environmental stimuli, such as insulin,
IGFs, oxidative stress, cytokines, and nutrients. In addition,
they may be critical to preventing aging and age-dependent
diseases. All FoxO proteins bind to the same consensus
sequence and hence can act in a redundant manner.
However, specific functions for particular FoxO isoforms
have been described, and this specificity can be partially
ascribed to their tissue-specific expression patterns (Biggs
et al., 2001; Jacobs et al., 2003).
Deletions of individual FoxO genes in mice have revealed
redundant isoform-specific functions of FoxO1, FoxO3a, and
FoxO4 (Van der Vos et al., 2011a, 2011b). The deletion of
FoxO1 is lethal as a result of incomplete vascular develop-
ment (Hosaka et al., 2004). FoxO3a-knockout mice show age-
dependent infertility as a result of global ovarian follicle
activation, which results in early oocyte depletion (Castrillon
et al., 2003). In contrast, no phenotype has yet been observed
for FoxO4 depletion (Hosaka et al., 2004). These results
suggest that the FoxO genes have critical roles in a wide
variety of cellular processes, particularly FoxO3a, which
functions in age-dependent cellular processes.
Each FoxO family is exquisitely regulated by posttransla-
tional modifications, which affect protein activity, cellular
localization, and stability. Reactive oxygen species (ROS)
regulate FoxO activity either by modulating the activity of
growth factor receptors, tyrosine kinases, serine/threonine
kinases, and phosphatases or by regulating lipid metabolism
through interactions with factors that are upstream of FoxO
(Van der Heide et al., 2004; Obsil and Obsilova, 2008;
Patridge and Bru¨ning, 2008). ROS inhibit or activate FoxO
factors in a context-dependent manner. Hydrogen peroxide
inhibits FoxO activity by activating the phosphoinositide
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3-kinase (PI3K)-protein kinase B pathway by exerting insulin-
mimetic effects (Heffetz et al., 1992), whereas ROS–activated
macrophage-stimulating 1, mitogen-activated protein kinase,
and c-Jun N-terminal kinase activate the FoxO proteins via
phosphorylation and disruption of binding to the 14-3-3
protein (Ueda et al., 2002; Essers and Weijzen, 2004; Bi
et al., 2010). These studies suggest that FoxO activity can be
positively or negatively regulated depending on the degree of
ROS accumulation and the duration of ROS signaling.
In skin, downregulation of FoxO3a accelerates cellular
senescence in human dermal fibroblasts (Kim et al., 2005).
As a pro-apoptotic gene, FoxO3a is negatively regulated by
Notch signaling in UVB–treated keratinocytes, thereby result-
ing in protection against UVB radiation (Mandinova et al.,
2008), and its nuclear translocation is also regulated by UV
irradiation through the c-Jun N-terminal kinase-extracellular
signal-regulated kinase/AKT pathway, which promotes
apoptosis (Wang et al., 2012). These studies suggest that
FoxO3a has an important role in cellular responses against
external stimuli in the skin, but the function of FoxO3a in
melanocytic cells has not yet been elucidated. As a photo-
protector for skin against UV irradiation, melanin is produced
by sequential oxidation processes through which tyrosine is
converted to eumelanin and pheomelanin. Because of their
oxidative properties, many antioxidants, such as vitamins C
and E, have been used to treat skin hyperpigmentation (Lerner
and Fitzpatrick, 1950; Hayakawa, 1980). In addition, the low
activity of catalase, the main enzyme responsible for
degrading hydrogen peroxide, is associated with the low
skin phototype; patients with this phototype burn relatively
easily, do not tan well, and are at a higher risk for skin cancer
compared with those with the high skin phototype (Picardo
et al., 1999), thereby suggesting a close relationship between
melanogenesis and redox state in the skin. However, the
mechanism that regulates redox state–dependent melanogen-
esis has not yet been studied in detail. Because FoxO3a
activity can be regulated by ROS, which in turn regulates
melanogenesis, we speculate that the melanogenesis alteration
induced by ROS perturbation may occur via FoxO3a-
mediated cell signaling.
In this study, we show that FoxO3a is an antimelanogenic
factor. We show that the knockdown of FoxO3a expression
using small interfering RNAs (siRNAs) greatly induced melanin
production and increased the expression of proteins that are
associated with melanogenesis. In contrast, the overexpression
of FoxO3a and the inhibition of PI3K or Akt resulted in
increased FoxO3a nuclear translocation and consequently
decreased melanogenesis. Furthermore, we verified the invol-
vement of FoxO3a in antioxidant-mediated depigmentation,
showing that antioxidants promoted the nuclear translocation
of FoxO3a and that FoxO3a-directed siRNA diminished these
antioxidant effects.
RESULTS
FoxO3a positively regulates melanogenesis in pigmented cells
FoxO3a has an important role in various pathways associated
with cell type– and environment-specific differentiation by
regulating the cell cycle machinery (Hu et al., 2008). In skin
cells, Foxo3a has a role both in the senescence of dermal
fibroblasts and in the response of keratinocytes to UV
irradiation. To investigate whether FoxO genes are involved
in melanocyte differentiation, we first assessed the expression
levels of FoxO1, FoxO3a, and FoxO4 in lightly pigmented
(LP), moderately pigmented (MP), and darkly pigmented
melanocytes and melanoma MNT1 cells (Figure 1a–c). Of
the FoxO family members, FoxO3a was expressed at more
than 10-fold higher levels than other FoxO proteins in these
pigment-related cells (Figure 1b), and its expression levels
decreased with increasing degree of pigmentation (Figure 1b
and c), suggesting an inverse relationship between FoxO3a
expression and melanin levels. To confirm that FoxO3a is
involved in melanogenesis, we treated cells with the PI3K
inhibitors LY294002 and wortmannin, which induce FoxO3a
activation (Yao and Cooper, 1995). When PI3K inhibitors
were applied to primary melanocytes, FoxO3a significantly
translocated to the nucleus (Figure 1d), melanin levels
decreased (Figure 1e), and the pigment-related proteins
tyrosinase (TYR), TYR-related protein 1 (TYRP1), and dopa-
chrome tautomerase (dopachrome delta-isomerase, TYR-
related protein 2, DCT) were downregulated (Figure 1f).
To verify that Foxo3a is the main factor in melanogenesis
regulation, we introduced siRNAs against FoxO3a into human
melanoma MNT1 cells, which are highly pigmented melano-
tic cells with mature stage III and IV melanosomes and express
relatively high levels of melanin (Figure 1a). We used two
different types of FoxO3a-directed siRNAs (si-1 and si-2) and
verified that both were functioning properly by qPCR and
immunoblot assay (Figure 2a and c). When FoxO3a-directed
siRNAs were introduced into cells, the expression of stem cell
factor (SCF), the SCF receptor (cKIT), and SRY-related
HMG-box (SOX10), which are associated with proliferation
rather than melanogenesis, was downregulated, whereas the
expression of pigment-related genes, such as microphthalmia-
associated transcription factor (MITF), TYR, TYRP1, and DCT,
was upregulated (Figure 2a and b). We further examined the
expression of several genes that have a role in early to
late melanogenesis. Compared with the BRN2, S100b, and
NOTCH1 levels, which were downregulated, the mRNA
levels of paired box transcription factor (PAX3), melanoma
antigen recognized by T cells (MART1), endothelin receptor B
(EDNRB), and p75NTR were increased by siRNAs against
FoxO3a (Supplementary Figure S1a and b online). Consistent
with the upregulation of pigment-related genes, the
protein levels of MITF, TYR, TYRP1, and DCT accumulated
(Figure 2c). Moreover, melanin levels (Figure 2d and e) and
TYR activity (Figure 2f) were significantly increased in
FoxO3a-directed siRNA-treated cells compared with control
or mock (negative control siRNA)-treated cells, suggesting that
FoxO3a inhibits melanogenesis by downregulating pigment-
related genes.
Elevated nuclear FoxO3a inhibits melanogenesis
FoxO family proteins function as downstream effectors of the
PI3K-protein kinase B (also called AKT) pathway (Burgering
and Kops, 2002). At the molecular level, activated PI3K-
protein kinase B phosphorylates FoxO3a, which reduces
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FoxO3a nuclear translocation and suppresses its
transactivation activity (Brunet et al., 1999; Kops et al.,
2002). Therefore, we used the well-known PI3K inhibitors
LY294002 and wortmannin to induce FoxO3a nuclear
translocation and activation (Yao and Cooper, 1995). When
PI3K inhibitors were applied to cells, the melanin levels
decreased by 59% (LY294002) and 60.3% (wortmannin)
compared with those in untreated groups (Figure 3a and b),
and the TYR activity was reduced by 57.8% and 54.6%,
respectively (Figure 3c). The mRNA expression levels of the
melanogenesis-related genes MITF, TYR, TYRP1, DCT, PAX3,
and EDNRB were reduced (Figure 3d and Supplementary
Figure S1c online), whereas the early-stage markers of mela-
nogenesis, such as SCF, cKIT, SOX10, BRN2, and NOTCH1,
were increased, which is in contrast to the results shown for
FoxO3a-directed siRNA expression (Figure 3e and
Supplementary Figure S1d online). We found that PI3K
inhibitors increased the mRNA and protein expression levels
of FoxO3a and subsequently enriched the protein in the
nuclear fraction (Figure 3e and f). In accordance with the
accumulation of FoxO3a in the nucleus, the protein expres-
sion of MITF, TYR, TYRP1, and DCT was downregulated,
suggesting that the elevated levels of FoxO3a in the nuclear
fraction inhibit melanogenesis (Figure 3f).
Nuclear translocation of FoxO3a is a key process in
melanogenesis regulation
As shown using FoxO3a-directed siRNA and PI3K inhibitors,
the levels and nuclear translocation of FoxO3a are associated
with melanogenesis; however, whether the level or location of
FoxO3a is more closely associated with melanogenesis reg-
ulation remains unclear. To examine the effect of FoxO3a
nuclear translocation on melanogenesis, we constructed
plasmids expressing wild-type (WT) FoxO3a (plasmid 1787:
HA-FoxO3a; WT) or mutant FoxO3a with a deletion in the
nuclear localization sequence (NLS), an essential region for
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Figure 1. The expression of forkhead box-O (FoxO) proteins in pigmented cells and the regulation of melanogenesis by FoxO3a in primary melanocytes. (a) The
melanin levels in lightly pigmented (LP), moderately pigmented (MP), and darkly pigmented (DP) melanocytes and MNT1 cells were visualized after dissolving cell
pellets in 1 N NaOH. (b) The mRNA expression levels of FoxO1, FoxO3a, and FoxO4 in the LP, MP, and DP melanocytes and in MNT1 cells. The data represent
three independent experiments (mean±SD). (c) The protein expression levels of FoxO proteins in pigmented cells were determined by western blot analysis.
(d) Primary melanocytes were treated with the phosphoinositide 3-kinase (PI3K) inhibitors LY294002 (500mM) or wortmannin (1mM) for 48 hours. The cells were
stained with an anti-FoxO3a antibody (FoxO3a; red) and 4’,6-diamidino-2-phenylindole (DAPI) (nucleus; blue). Images were obtained by fluorescence microscopy
and merged. Representative images are shown. Control, vehicle alone treated; Ph, phase-contrast image. Bar¼200mm. Cells with FoxO3a localization were
counted and depicted by means of an EVOSfl digital fluorescence microscope. (e) The PI3K inhibitors LY294002 (500mM) and wortmannin (1mM) were used to treat
primary melanocytes for 5 days, and the melanin levels were then visualized. The quantitative melanin levels were determined by measuring absorbance at
490 nm using a spectrophotometer. *Po0.05. (f) Primary melanocytes were treated with the PI3K inhibitors LY294002 (500mM) or wortmannin (1mM) for 48 hours,
and then the cell lysates were analyzed by western blotting. Control: vehicle alone treated.
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FoxO3a function (Brownawell et al., 2001) (plasmid 8361:
FLAG-FoxO3a TM; DNLS). When MNT1 cells were
transfected with the WT or mutant constructs, the total level
of FoxO3a proteins greatly increased under both conditions
(Figure 3g, lower panel, whole FoxO3a), whereas the nuclear
FoxO3a levels were increased only under the WT overexpres-
sion condition (Figure 3g, upper panel). In addition, the
melanin levels greatly decreased in the WT–expressing cells
but not in the mutant-expressing cells (Figure 3h), indicating
that nuclear translocation, rather than Foxo3a protein levels, is
associated with melanogenesis. FoxO3a activation is induced
by its nuclear translocation (Van der Heide et al., 2004).
Therefore, the regulation of melanogenesis by FoxO3a is
dependent on its activation through nuclear translocation. To
confirm that FoxO3a nuclear translocation is the main factor
for melanogenesis inhibition, we next assessed Akt inhibition
by Akt-directed siRNA or an Akt inhibitor. The treatment with
siRNA against Akt or with an Akt inhibitor decreased melanin
by 61.7% and 59%, respectively, whereas FoxO3a-directed
siRNA increased melanin production by 114.8% (Figure 3i).
The phosphorylation of FoxO3a was blocked by the inhibition
of Akt (Figure 3j), and the nuclear translocation of FoxO3a
was greatly increased by Akt inhibition (Figure 3k). On the
basis of these results, we suggest that FoxO3a nuclear
translocation by either PI3K or Akt inhibition results in the
suppression of melanogenesis.
FoxO3a mediates the antimelanogenic activity of antioxidants
and PI3K inhibitors
Because several enzymatic oxidation steps occur during
melanin synthesis, many antioxidants have been used to treat
skin hyperpigmentation. Hydroquinone, vitamin C (Vc), vita-
min E, and N-acetylcysteine (NAC) have been widely used to
reduce melanin levels, and their synergetic effects have been
shown (Fujiwara et al., 2004; Hu et al., 2009). However, the
mechanism by which antioxidants regulate melanogenesis has
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Figure 2. Forkhead box-O3a (FoxO3a) regulates melanogenesis by modulating melanogenic genes. MNT1 cells were transfected with small interfering RNAs
(siRNAs) against FoxO3a for 48 hours. Genes that were (a) downregulated or (b) upregulated were analyzed by means of quantitative real-time reverse-
transcriptase–PCR (RT-qPCR). *Po0.05. (c) After treatment with FoxO3a siRNAs, the cell lysates were analyzed by western blot analysis. The (d, e) melanin levels
and (e, f) tyrosinase activity were assessed by measuring absorbance at 490 nm with a spectrophotometer. Control: untreated; mock: control siRNA; si-1, -2: siRNA
against FoxO3a. The values are presented as the mean±SD of three independent experiments. *Po0.05. cKIT, DCT, DopaChrome Tautomerase; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; MITF, microphthalmia-associated transcription factor; SCF, stem cell factor; SOX10, SRY-related HMG-box;
TYR, tyrosinase; TYRP1, tyrosinase-related protein 1.
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not yet been investigated in detail. To elucidate this
mechanism, we first examined the effects of representative
antioxidants, including Vc, NAC, and Trolox (a water-soluble
derivative of vitamin E), on pigmentation. As previously
reported (Fujiwara et al., 2004), the melanin levels and TYR
activity gradually decreased to a certain extent following
antioxidant treatment. However, these effects were transient,
and the melanin levels and TYR activity gradually increased
with increases in antioxidant concentrations higher than
100 nM (Figure 4a). Although each antioxidant is structurally
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Figure 3. Melanogenesis regulation by forkhead box-O3a (FoxO3a) is mediated via its nuclear translocation. (a) MNT1 cells were treated with the
phosphoinositide 3-kinase (PI3K) inhibitors LY294002 (500mM) and wortmannin (1mM) for 48 hours, and the melanin levels were visualized. The (b) quantitative
melanin levels and (c) tyrosinase activity were determined by measuring absorbance at 490 nm using a spectrophotometer. After treatment with the PI3K inhibitors,
the expression of various genes was examined by quantitative real-time reverse-transcriptase–PCR (RT-qPCR), and the (d) downregulated and (e) upregulated genes
are shown. *Po0.05. The data are presented as the mean±SD of three independent experiments. (f) The cells were fractionated into cytosolic and nuclear portions
after PI3K inhibitor treatment, and each protein, including FoxO3a, was analyzed by western blot analysis. Lamin B was used as a marker of the nuclear fraction.
C, untreated; M, vehicle alone treated; Ly, LY294002; Wort, wortmannin. (g) Constructs for wild-type FoxO3a (WT) or mutant FoxO3a harboring a deleted nuclear
localization signal (DNLS) were transfected into MNT1 cells, and the cells were fractionated into cytosolic and nuclear portions. FoxO3a expression was analyzed
by western blot. NT, non-treated; DNLS, nuclear localization signal deleted. (h) The melanin levels were visualized after overexpression of the WT or mutant
FoxO3a. The MNT1 cells were transfected with small interfering RNAs (siRNAs) against FoxO3a or Akt; the treatment with 10mM Akt inhibitor was performed for
48 hours. (i) The melanin levels were visualized and quantified by measuring absorbance at 490 nm, and (j) the protein levels of Akt, phosphorylated (p)-Akt,
FoxO3a, and p-FoxO3a were analyzed by western blot. Con: vehicle alone treated; mock: control siRNA. (k) MNT1 cells were transfected with siRNAs against
FoxO3a or Akt; treatment with 10mM Akt inhibitor was performed for 48 hours. The cells were stained with an anti-FoxO3a antibody (FoxO3a; red) and 4’,6-
diamidino-2-phenylindole (DAPI) (nucleus; blue). The representative images were obtained under fluorescence microscopy and merged. Ph, phase-contrast image.
Bar¼200mm. Cells with FoxO3a localization were counted and depicted by means of an EVOSfl digital fluorescence microscope. cKIT, SCF receptor; DCT,
DopaChrome Tautomerase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MITF, microphthalmia-associated transcription factor; SCF, stem cell factor;
SOX10, SRY-related HMG-box; TYR, tyrosinase; TYRP1, tyrosinase-related protein 1.
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different, they displayed very similar melanogenesis inhibition
patterns. In the overall concentration range, in vitro TYR
activity, cell proliferation, and cytotoxicity were not affected
by each antioxidant (Supplementary Figure S2 online). Next,
we examined the expression of pigment-related genes after
treatment with 100 nM of each antioxidant. The mRNA and
protein levels of MITF and TYRP1 remained unchanged,
whereas the levels of TYR and DCT were significantly reduced
(Figure 4b and c).
On the basis of a previous study showing the translocation
of DAF-16 (a homolog of Foxo3a) from the cytosol to the
nucleus in response to antioxidants in C. elegans (Kampko¨tter
et al, 2007), we hypothesized that FoxO3a activation by
nuclear translocation is involved in the antimelanogenic
processes induced by antioxidants. To test this hypothesis,
we performed immunofluorescence assays. Increasing
concentrations of each antioxidant (Vc, NAC, and Trolox)
induced the nuclear translocation of FoxO3a, showing the
gradual enrichment of FoxO3a within the nucleus up to
100 nM and a gradual reduction at greater concentrations
(Supplementary Figure S3 online). These results suggest that
melanogenesis is modulated by Foxo3a nuclear translocation,
which is in turn regulated by antioxidants. We confirmed the
nuclear localization of FoxO3a after treatment with 100 nM of
each antioxidant, which was the concentration that yielded
the greatest antimelanogenic activity (Figure 5a). Without a
change in the total protein levels (Figure 5b), endogenous
FoxO3a was enriched in the nuclear fraction of antioxidant-
treated cells compared with non-treated control cells
(Figure 5c). To uncover how FoxO3a nuclear translocation
occurs, we performed a time-course experiment. The results
showed that FoxO3a localized to the nucleus after 2 hours and
that this process gradually strengthened with time (Figure 5d).
FoxO3a nuclear localization occurs relatively quickly and
directly, and this response is continuous rather than transient
(Figure 5d). Meanwhile, the nuclear translocation of another
FoxO protein, FoxO1, induced by antioxidants was not
observed (Supplementary Figure S4 online).
To ensure that the antimelanogenic effect of antioxidants
was mediated by FoxO3a activation, we pretreated MNT1
cells with FoxO3a siRNA and then applied 100 nM of each
antioxidant. As expected, cells that were pretreated with
FoxO3a siRNA displayed increased melanin levels and TYR
activity compared with control or mock-treated cells
(Figure 6a-c). The increased melanin levels and TYR activity
following the FoxO3a siRNA treatment were not significantly
reversed by any antioxidant treatment (Figure 6a-c) at any
dose (Figure 6d). In addition, the increased melanogenesis
induced by FoxO3a siRNA was not reduced remarkably by
treatment with the PI3K inhibitor (Figure 6e). Although some
doses of antioxidants and wortmannin decreased the melanin
in FoxO3a siRNA-treated samples, such decreases did not
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Figure 4. Antioxidants reduce melanogenesis by the inhibition of tyrosinase (TYR) and DopaChrome Tautomerase (DCT). (a) The melanin levels were
visualized and quantified after treatment with each antioxidant at various concentrations for 48 hours by measuring absorbance at 490 nm (upper panel). The TYR
activity is shown (lower panel). After treatment with each antioxidant (100 nM) for 48 hours, the mRNA and protein expression levels of melanogenesis-related
genes were analyzed by (b) quantitative real-time reverse-transcriptase–PCR (RT-qPCR) and (c) western blot. *Po0.05. Con, vehicle only treated; Vc, vitamin C;
NAC, N-acetylcysteine. The data shown are the mean±SD of three independent experiments. cKIT, SCF receptor; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase; MITF, microphthalmia-associated transcription factor; SCF, stem cell factor; TYRP1, tyrosinase-related protein 1.
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occur to a distinct degree. These results imply that FoxO3a is
an essential factor for the antimelanogenic activity of antiox-
idants and PI3K inhibitors.
DISCUSSION
Melanogenesis involves a series of tightly regulated enzymatic
oxidation processes, which culminate in the synthesis and
assembly of the melanin polymer. Therefore, many antiox-
idative agents have been used to treat skin hyperpigmentation;
however, the regulatory mechanism is unknown. FoxO3a
regulates many target genes that are involved in the antiox-
idative response in various cell types, including skin cells. In
this study, we suggest that FoxO3a is involved in the
regulation of melanogenesis and is a mediator of antimelano-
genic effects. We verified that FoxO3a is an antimelanogenic
factor by evaluating the effects of its knockdown and over-
expression and the activation of FoxO3a using PI3K inhibitors
and Akt inhibition. We also showed that the antimelanogenic
activity of antioxidants is mediated by FoxO3a activation via
its nuclear translocation.
The antimelanogenic effects of antioxidants and PI3K inhibitors
are mainly mediated by FoxO3a activation
One possible explanation for the antimelanogenic effect of
antioxidants is that they inhibit melanin synthesis by simply
reducing cellular ROS levels. However, based on our results,
the antimelanogenic effect of antioxidants appears to be
mediated by FoxO3a activation (Figures 5 and 6), providing
a reasonable molecular mechanism. In response to simple
antioxidant treatments at various concentrations, we observed
that the melanin levels and TYR activity were decreased to a
certain extent; the maximum decrease was observed at
100 nM, and higher concentrations led to reduced effects.
These phenomena were well coordinated with the nuclear
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translocation of FoxO3a (Figures 4 and 5 and Supplementary
Figure S3 online). Hermetic (bell-shaped or U-shaped) con-
centration effect curves are often observed for many chemi-
cals, including toxins, drugs, oxidants, and antioxidants
(Cornelius et al., 2013). FoxO transcription factors are
considered key factors in redox signaling because they
control the transcription of ROS-scavenging enzymes and,
inversely, FoxO activity is post-translationally modulated by
ROS (de Keizer et al., 2011). Recently, the cysteine residues in
FoxO have been reported to act as sensors for the local redox
state and to be involved in the interaction with nuclear import
receptor transportin-1 via disulfide formation. The different
redox states result in varying stability of the interaction and
extent of FoxO nuclear translocation (Putker et al., 2013). This
finding may explain why antioxidant doses higher than 100 nM
do not consistently enhance, but rather reduce, FoxO3a
nuclear translocation. The reduced FoxO3a nuclear
translocation at antioxidant concentrations higher than
100 nM may be partly because of cellular defense mecha-
nisms against hyper-reductive conditions, for which cells
activate a signaling pathway for reoxidation initiated by the
FoxO protein after sensing a hyper-reductive state for a
physiological balance between the oxidative and reductive
states. High levels of antioxidants may induce a hyper-
reductive state inside cells, which inhibits disulfide formation
with binding partners, reduces FoxO nuclear translocation,
and reduces the transcription of ROS-scavenging enzymes.
Because FoxO3a overexpression or activation using PI3K
inhibitors influenced the expression of MITF, TYR, TYRP-1,
and DCT (Figure 3), FoxO3a activation by antioxidants
appears to affect selectively the expression of TYR and DCT
(Figure 4), suggesting that antioxidants most likely influence
the expression of melanogenesis-related genes through
mechanisms other than the FoxO3a pathway. In addition,
various dose ranges of antioxidant and PI3K inhibitors could
not recover the increased melanin caused by pretreatment
with FoxO3a siRNA (Figure 6), indicating that FoxO3a
activation is a major factor for this phenomenon.
Possible interaction of FoxO3a with other melanogenic proteins
Although FoxO3a was proven to be a factor for the regulation
of melanogenesis in our study, the mechanism by which
FoxO3a regulates many melanogenesis-related genes remains
unknown. Because FoxO3a interacts and forms a complex
with many proteins, FoxO3a may bind to melanogenesis-
related factors working within the nucleus to generate high-
molecular-weight complexes and perform functions that are
associated with melanogenesis. The FoxO family members
contain one forkhead-binding domain fused with the tran-
scriptional activation domain of the respective forkhead factor,
which interacts with the DNA-binding domain of other
transcription factors, thereby generating a chimeric form
(Van der Vos et al., 2011a, 2011b). Similarly, the PAX3-
FoxO1 chimeric form has been found in alveolar
rhabdomyosarcoma and consists of the transactivation and
DNA-binding domains of FoxO1 and PAX3, respectively (Hu
et al., 2008), suggesting that PAX3 and FoxO3a may interact.
Another putative binding target of FoxO3a is peroxisome
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Figure 6. Forkhead box-O3a (FoxO3a) is a major target of melanin synthesis by antioxidant and phosphoinositide 3-kinase (PI3K). FoxO3a small interfering
RNAs (siRNAs) were applied to MNT1 cells, and the cells were then treated with (a–c) 100 nM of each antioxidant, (d) a 0–100mM dose range of vitamin C, or (e)
with PI3K inhibitors. (a, b, d, e) The melanin levels were visualized and quantified, and (c) tyrosinase activity was determined by measuring absorbance at 490 nm.
Con, vehicle alone treated; mock, control siRNA treated; si, siRNA against FoxO3a; Vc, vitamin C; NAC, N-acetylcysteine. The data shown are the mean±SD of
three independent experiments. *Po0.05.
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proliferator–activated receptor gamma coactivator-1a, which
activates MITF in human melanoma cell lines and is regulated
by alpha-melanocyte stimulating hormone (a-MSH) (Shoag
et al., 2013). Peroxisome proliferator–activated receptor
gamma coactivator -1a is regulated by FoxO factors tran-
scriptionally and post-translationally and can cooperate with
FoxO (Corton and Brown-Borg, 2005). Considering that our
results show that the deletion of FoxO3a using siRNA
upregulated the PAX3 and MITF mRNA levels and that
FoxO3a activation via PI3K inhibitors reversed this effect,
PAX3 and peroxisome proliferator–activated receptor gamma
coactivator-1a do not appear to be direct transcriptional
targets of FoxO3a. However, these factors may still represent
binding partners of FoxO3a for melanogenesis regulation. We
also speculate that other factors such as SCF, cKIT, and
SOX10, for which the expression levels correlated with
FoxO3a expression and activation, may be transcriptional
targets of FoxO3a.
In conclusion, inhibiting melanogenesis by manipulating
the production of ROS or the activity of cellular regulators of
ROS has been considered an attractive therapeutic target for
hyperpigmentation and melanoma. Typically, pharmacologi-
cal agents have been designed to reduce melanin synthesis
through the antioxidative process and have focused primarily
on eliminating ROS. On the basis of our study, FoxO3a
mediates the antioxidant effect on cellular functions, including
melanogenesis, and may represent a potent target for regulat-
ing those signaling pathways. Because FoxO3a is associated
with longevity in humans and in C. elegans, which is a model
organism for studying aging, this study suggests that FoxO3
may represent a potent target for pursuing both antiaging and
antimelanogenic effects.
MATERIALS AND METHODS
Antibodies and reagents
Antibodies against MITF (C5), TYR (H-109), TYRP-1 (H-90), DCT
(C-9), GAPDH (FL-335), and lamin B (C-5) were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). MITF (Neomarkers, Fremont,
CA) and TYR (Upstate Biotechnology, Lake Placid, NY) antibodies
were also used. FoxO3a (no. 9467), FoxO3a (75D8), FoxO1 (C29H4),
FoxO4 (55D4), phospho-FoxO3a (no. 9466), Akt (no. 9272), and
phosphor-Akt (no. 4060) antibodies were purchased from Cell
Signaling Technology (Beverly, MA). The PI3K inhibitors LY294002
and wortmannin were purchased from Cell Signaling Technology. Akt
inhibitor 1/2 (A6730) was obtained from Sigma (St Louis, MO).
Secondary antibodies for western blot and immunofluorescence were
obtained from Cell Signaling Technology and Invitrogen (Carlsbad,
CA), respectively. Plasmids for HA-FoxO3a WT (1787) and the NLS
mutant, FLAG-FoxO3a TM (8361), were obtained from Addgene
(Cambridge, MA). FoxO3a-validated stealth RNA interference (RNAi)
duopak and scramble RNAi were purchased from Invitrogen.
Cell culture and growth activity assay
MNT1 cells were maintained in minimum essential media (Gibco,
Grand Island, NY) containing 10% DMEM, 20 mM HEPES (Sigma),
20% fetal bovine serum, 100 U ml 1 penicillin G, and 100mg ml 1
streptomycin sulfate. MNT1 cells were incubated at 37 1C with 5%
CO2 and regularly passaged at a density of 80% (1:8 ratio). Cell
proliferation and cytotoxicity were measured using cell counting kit-8
(Dojindo, Kumamoto, Japan).
TYR enzymatic activity assay and determination of melanin
levels
To assess cellular TYR activity, equal amounts of cell lysates (10mg)
were incubated with 10 mM L-dihydroxyphenylalanine (pH 6.8) at
37 1C for 1 hour. Melanin synthesized from L-dihydroxyphenylalanine
by TYR in the cell extracts was measured at 490 nm in a UV–vis
spectrometer (Molecular Devices, Sunnyvale, CA). Mushroom TYR
catalytic activity was measured by incubating 2 mg ml 1 mushroom
TYR (Sigma) with 10 mM L-dihydroxyphenylalanine solution supple-
mented with the reagents of interest at 37 1C for 1 hour. Melanin
levels were measured at 490 nm. To measure cellular melanin levels,
the cell pellets were dissolved in 1 N sodium hydroxide, and melanin
levels were determined by measuring absorbance at 490 nm. The
melanin levels were normalized to protein input.
Small interfering RNA and plasmid transfection
MNT1 cells cultured in 60 mm dishes were transfected with stealth
RNAi duopak FoxO3a (cat. no. 45-1712; Invitrogen), SignalSilence
Akt siRNA (no. 6211; Cell Signaling Technology), and a Stealth RNAi
siRNA negative control kit (cat. no. 12935-100; Invitrogen) using
Lipofectamine RNAi MAX (Invitrogen) and 5 nM siRNA for 48 hours,
according to the manufacturer’s instructions. MNT1 cells (3.5 105
cells per 6 wells) were grown to 60–70% confluence and then
transfected with 4mg of plasmid. The plasmids included constitutively
active HA-FoxO (1787; Addgene) and constitutively active FoxO3a
NLS mutant, FLAG-FoxO3a TM (8367; Addgene).
FoxO localization assay using immunofluorescence
MNT1 cells were treated with each reagent (Vc, NAC, and Trolox) for
4 days, washed with phosphate-buffered saline, fixed for 30 minutes
in 4% paraformaldehyde, washed again, and incubated for 10 min in
0.1% Triton X-100. The cells were washed three times in phosphate-
buffered saline and incubated with anti-FoxO3a (1:200) or anti-
FoxO1 antibodies (1:200) diluted in Hank’s solution (0.44 mM
KH2PO4, 5.37 mM KCl, 0.34 mM Na2HPO4, 136.89 mM NaCl, and
5.55 mM D-glucose) at 4 1C overnight. Secondary antibodies (Alexa
Fluor 555– or Alexa Fluor 488–conjugated goat anti-rabbit or -mouse)
were added for 1 hour at room temperature. After washing, the
coverslips were mounted onto glass slides and visualized using an
EVOSfl digital fluorescence microscope (Advanced Microscopy
Group, Mill Creek, WI) (Ex: 555 nm, Em: 565 nm for FoxO3a; Ex:
488 nm, Em: 519 nm for FoxO1).
Cellular fractionation assay
Cytoplasmic and nuclear fractions were prepared according to a
previously published protocol (Schreiber et al., 1989). Briefly, the
cells were lysed in a cytosolic lysis buffer containing 10 mM HEPES
(pH 7.9), 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 10% NP-40,
0.5 mM phenylmethyl sulfonyl, 1 mM dithiothretiol, and protease
inhibitors. The nuclei were pelleted via a short centrifugation step
and lysed in a nuclear buffer containing 20 mM HEPES (pH 7.9),
400 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1 mM phenylmethyl sulfonyl,
1 mM dithiothretiol, and protease inhibitors. The nuclear pellets were
subjected to three freeze–thaw cycles before they were sonicated and
centrifuged to obtain a solubilized nuclear fraction.
J Kim et al.
FoxO3a Regulates Melanogenesis
1386 Journal of Investigative Dermatology (2014), Volume 134
Western blot analysis
MNT1 cells were lysed in lysis buffer containing 20 mM Tris-HCl (pH
7.5), 150 mM NaCl, 1 mM dithiothretiol, 0.5% NP-40, 25 mM b-
glycerophosphate, 1 mM sodium orthovanadate, 0.5 mM phenylmethyl
sulfonyl, and a protease inhibitor cocktail (protease inhibitor; Sigma)
and incubated with the appropriate antibodies for 1 hour. This
incubation was followed by the addition of precleared protein G
beads (GE Healthcare, Chalfont St Giles, UK) overnight at 4 1C. Next,
the beads were washed five times with lysis buffer. Western blotting
was performed following standard protocols. The cell lysates (20mg
protein) were boiled in SDS sample buffer and resolved using 4–12%
SDS-PAGE. The proteins were then transferred to a polyvinylidene
difluoride membrane (Invitrogen) and probed using specific
antibodies.
Quantitative real-time reverse-transcriptase–PCR
MNT1 cells were homogenized in TRIzol reagent (Gibco), and total
RNA was extracted according to a standard protocol. Total RNA
(4mg) was reverse-transcribed using random hexamers and Super-
Script III (Invitrogen) according to the manufacturer’s instructions.
Quantitative PCR was performed using the ABI 7500 Fast Real-Time
PCR System with Taqman Universal Master Mix II (Applied
Biosystems, Foster City, CA) and TaqMan site-specific primers and
probes (Applied Biosystems). We used the DDCT analysis method
(Schmittgen and Livak, 2008); the efficiency of the target and the
reference amplification were approximately equal. Reactions were
performed in triplicate, and mRNA expression levels were quantified
using the relative CT method and normalized to GAPDH level.
Statistical analysis
For quantitative real-time reverse-transcriptase–PCR (RT-qPCR), data
are shown as the mean±SD of at least three triplicate measurements.
The P-values generated after a two-tailed Student’s t-test were used to
compare DCT values between the control and treatment groups. All
statistical tests were two-sided, and the threshold for statistical
significance was 0.05 (*Po0.05).
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